T cell profiling reveals high CD4+CTLA-4+ T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment - Concepedia

Concepedia

Publication | Open Access

T cell profiling reveals high CD4+CTLA-4+ T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment

DOI Full Paper Access

91

Citations

40

References

2012

Year

Saskia J. Santegoets, Anita G.M. Stam, Sinéad M. Lougheed, Helen Gall, Petra E.T. Scholten, Martine Reijm, Karin Jooss, Natalie Sacks, Kristen Hege, Israel Lowy,

Cancer Immunology Immunotherapy

Prostate Gvax/ipilimumab TreatmentUrologyCancer ImmunosurveillanceImmunologyAutoimmunityT CellProstatic DiseaseImmunotherapyMedicineDominant PredictorTumor Microenvironment

References

	Year	Citations

Page 1

Page 1